Haryana Resumes Ayushman Bharat Payments, Delays Withdrawal by 650 Private Hospitals

Chandigarh, August 6, 2025 — Hours before a mass withdrawal by 650 private hospitals was set to take effect under Ayushman Bharat – AB‑PMJAY, the Haryana State Health Agency (SHA) confirmed that payment processing has resumed. The release of new funding has halted the immediate threat to suspend services that would have affected 1.8 crore beneficiaries across the state.

 

The SHA began clearing claims on August 4, following receipt of the state’s budget allocation. Hospitals are being paid on a first‑in‑first‑out (FIFO) basis, and claims up to the first week of May 2025 have been settled. SHA officials noted that ₹2,900 crore has been disbursed to hospitals since the scheme launched, including ₹240.63 crore so far.

On July 28, the Haryana chapter of thehttp://Indian Medical Association Indian Medical Association (IMA) issued a warning. It threatened to pull hospitals out of the Ayushman scheme from August 7 if ₹500 crore in unpaid reimbursements were not cleared. Despite some payments, many hospitals had received just 10–15% of their claims since March.

 

SHA Actions and Reforms

 

The SHA has confirmed transparent processes via the National Health Authority (NHA) portal, using a 50-member doctor team to manage claim allocations impartially. Hospitals have an opportunity to upload missing documentation before deductions. If defaults occur, hospitals can appeal via a Medical Audit Committee, and 400 grievances have already been resolved via the CGRMS 2.0 platform.

To deepen transparency, IMA representatives are now included in district and state-level audit and grievance redress committees. NABH incentive applications continue under revised rules via the HEM 2.0 portal, replacing HEM 1.0.

Remaining Risks and Warnings

Despite the progress, IMA Haryana has maintained its stance. Former IMA President Dr Ajay Mahajan emphasised that unless all dues are satisfactorily cleared, hospitals may still withdraw services from August 7, disrupting planned surgeries and inpatient care. Emergency services would continue, but non-critical care may be

This crisis highlights a fragile ecosystem: hospitals provide free care upfront and rely heavily on government reimbursements. Prolonged delays strain operations and threaten the credibility of http://Ayushman BharatAyushman Bharat, India’s flagship universal health coverage programme. Maintaining timely public–private collaboration is essential for sustaining healthcare access across Haryana.

 

Related Posts

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

AiMeD welcomes the move long overdue to boost India’s Regulatory Framework New Delhi: 21 Drug Inspectors have been promoted to Assistant Drugs Controllers (India) under CDSCO. It was long unmet…

Yashoda Medicity lifts Benchmark in Critical Care to New High

With the introduction of North India’s first Advanced VitalGo Total Lift Bed Technology Ghaziabad/ New Delhi: In an ideal hospital, critical care is most paramount and it is also the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

IIT Guwahati Develops ‘E-Eye’ for Rapid Detection of Cancer-Causing Heavy Metals and Other Toxicants

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

AB-PMJAY Crackdown: 2,359 Hospitals De-empanelled, 1,200 Suspended for Violating Scheme Guidelines, Nadda Tells Lok Sabha

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad